 |
nivolumab |
|---|---|
| Trade Name | Opdivo |
| Orphan Indication | Anal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-07 00:00:00 |
| Sponsor | Bristol-Myers Squibb Co.;5 Research Parkway;Wallingford, Connecticut, 06492 |
| |
nivolumab |
|---|---|
| Trade Name | Opdivo |
| Orphan Indication | Anal cancer |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-07 00:00:00 |
| Sponsor | Bristol-Myers Squibb Co.;5 Research Parkway;Wallingford, Connecticut, 06492 |